{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:16:07Z","timestamp":1762161367712,"version":"build-2065373602"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s00417-025-06875-w","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T05:30:50Z","timestamp":1750051850000},"page":"2885-2892","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intraocular inflammation following intravitreal injections of anti-vascular endothelial growth factor drugs"],"prefix":"10.1007","volume":"263","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3592-2820","authenticated-orcid":false,"given":"Ana Margarida","family":"Ferreira","sequence":"first","affiliation":[]},{"given":"Ant\u00f3nio Ferr\u00e3o","family":"Mendes","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o Nuno","family":"Beato","sequence":"additional","affiliation":[]},{"given":"Ana Catarina","family":"Pedrosa","sequence":"additional","affiliation":[]},{"given":"Susana","family":"Penas","sequence":"additional","affiliation":[]},{"given":"S\u00f3nia","family":"Torres-Costa","sequence":"additional","affiliation":[]},{"given":"Cl\u00e1udia Oliveira","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"Carolina","family":"Maia","sequence":"additional","affiliation":[]},{"given":"Manuel","family":"Falc\u00e3o","sequence":"additional","affiliation":[]},{"given":"\u00c2ngela","family":"Carneiro","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"issue":"11","key":"6875_CR1","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1097\/IAE.0000000000003582","volume":"42","author":"NS Patil","year":"2022","unstructured":"Patil NS, Dhoot AS, Popovic MM, Kertes PJ, Muni RH (2022) Risk of intraocular inflammation after injection of antivascular endothelial growth factor agents: a meta-analysis. Retina 42(11):2134\u20132142","journal-title":"Retina"},{"issue":"1","key":"6875_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40942-021-00307-7","volume":"7","author":"WJ Anderson","year":"2021","unstructured":"Anderson WJ, da Cruz NFS, Lima LH, Emerson GG, Rodrigues EB, Melo GB (2021) Mechanisms of sterile inflammation after intravitreal injection of antiangiogenic drugs: a narrative review. Int J Retina Vitreous 7(1):37","journal-title":"Int J Retina Vitreous"},{"key":"6875_CR3","first-page":"773","volume":"9","author":"DK Sigford","year":"2015","unstructured":"Sigford DK, Reddy S, Mollineaux C, Schaal S (2015) Global reported endophthalmitis risk following intravitreal injections of anti-VEGF: a literature review and analysis. Clin Ophthalmol 9:773\u2013781","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"6875_CR4","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1177\/2474126418806832","volume":"3","author":"SG Schwartz","year":"2019","unstructured":"Schwartz SG, Flynn HW Jr, Emerson GG, Choudhry N, Ferrone PJ, Goldberg RA et al (2019) Distinguishing between infectious endophthalmitis and noninfectious inflammation following intravitreal anti-VEGF injection. J VitreoRetinal Dis 3(1):42\u201344","journal-title":"J VitreoRetinal Dis"},{"issue":"3","key":"6875_CR5","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/ICU.0000000000000154","volume":"26","author":"HF Fine","year":"2015","unstructured":"Fine HF, Despotidis GD, Prenner JL (2015) Ocular inflammation associated with antivascular endothelial growth factor treatment. Curr Opin Ophthalmol 26(3):184\u2013187","journal-title":"Curr Opin Ophthalmol"},{"issue":"4","key":"6875_CR6","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1097\/IAE.0000000000000398","volume":"35","author":"HF Fine","year":"2015","unstructured":"Fine HF, Roth DB, Shah SP, Haque T, Wheatley HM (2015) Frequency and characteristics of intraocular inflammation after aflibercept injection. Retina 35(4):681\u2013686","journal-title":"Retina"},{"issue":"1","key":"6875_CR7","doi-asserted-by":"publisher","first-page":"22122","DOI":"10.1038\/s41598-020-79377-w","volume":"10","author":"M Morioka","year":"2020","unstructured":"Morioka M, Takamura Y, Nagai K, Yoshida S, Mori J, Takeuchi M et al (2020) Incidence of endophthalmitis after intravitreal injection of an anti-VEGF agent with or without topical antibiotics. Sci Rep 10(1):22122","journal-title":"Sci Rep"},{"issue":"1","key":"6875_CR8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40942-023-00490-9","volume":"9","author":"VC Bergamo","year":"2023","unstructured":"Bergamo VC, Nakayama LF, Moraes NSBD, Yu MCZ, H\u00f6fling-Lima AL, Maia M (2023) Bacterial endophthalmitis following anti-VEGF intravitreal injections: a retrospective case series. Int J Retina Vitreous 9(1):58","journal-title":"Int J Retina Vitreous"},{"issue":"4","key":"6875_CR9","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3928\/15428877-20110603-04","volume":"42","author":"CN Kay","year":"2011","unstructured":"Kay CN, Tarantola RM, Gehrs KM, Folk JC, Mahajan VB, Boldt HC et al (2011) Uveitis following intravitreal bevacizumab: a non-infectious cluster. Ophthalmic Surg Lasers Imaging 42(4):292\u2013296","journal-title":"Ophthalmic Surg Lasers Imaging"},{"issue":"5","key":"6875_CR10","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1097\/IAE.0000000000000801","volume":"36","author":"PD Williams","year":"2016","unstructured":"Williams PD, Chong D, Fuller T, Callanan D (2016) NONINFECTIOUS VITRITIS AFTER INTRAVITREAL INJECTION OF ANTI-VEGF AGENTS: Variations in Rates and Presentation by Medication. Retina 36(5):909\u201313","journal-title":"Retina"},{"issue":"5","key":"6875_CR11","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3341\/kjo.2015.29.5.325","volume":"29","author":"JY Kim","year":"2015","unstructured":"Kim JY, You YS, Kwon OW, Kim SH (2015) Sterile inflammation after intravitreal injection of aflibercept in a korean population. Korean J Ophthalmol 29(5):325\u2013330","journal-title":"Korean J Ophthalmol"},{"issue":"7","key":"6875_CR12","first-page":"5672","volume":"65","author":"S Patel","year":"2024","unstructured":"Patel S, Chi G, Patel V, Boucher N, Aggarwal N, Chang S-C et al (2024) Retinal vasculitis with or without retinal vascular occlusion among eyes with nAMD or DME treated with IVT agents as recorded in the vestrum database. Investig Ophthalmol Vis Sci 65(7):5672","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"2","key":"6875_CR13","first-page":"123","volume":"48","author":"AR Anand","year":"2000","unstructured":"Anand AR, Therese KL, Madhavan HN (2000) Spectrum of aetiological agents of postoperative endophthalmitis and antibiotic susceptibility of bacterial isolates. Indian J Ophthalmol 48(2):123\u2013128","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"6875_CR14","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/s41598-018-37502-w","volume":"9","author":"D Deshmukh","year":"2019","unstructured":"Deshmukh D, Joseph J, Chakrabarti M, Sharma S, Jayasudha R, Sama KC et al (2019) New insights into culture negative endophthalmitis by unbiased next generation sequencing. Sci Rep 9(1):844","journal-title":"Sci Rep"},{"issue":"1","key":"6875_CR15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00417-007-0660-z","volume":"246","author":"L Wu","year":"2008","unstructured":"Wu L, Mart\u00ednez-Castellanos MA, Quiroz-Mercado H, Arevalo JF, Berrocal MH, Farah ME et al (2008) Twelve-month safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American collaborative retina study group (PACORES). Graefes Arch Clin Exp Ophthalmol 246(1):81\u201387","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"6875_CR16","doi-asserted-by":"publisher","first-page":"100862","DOI":"10.1016\/j.preteyeres.2020.100862","volume":"80","author":"GB Melo","year":"2021","unstructured":"Melo GB, Cruz N, Emerson GG, Rezende FA, Meyer CH, Uchiyama S et al (2021) Critical analysis of techniques and materials used in devices, syringes, and needles used for intravitreal injections. Prog Retin Eye Res 80:100862","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"6875_CR17","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/jps.24184","volume":"104","author":"E Krayukhina","year":"2015","unstructured":"Krayukhina E, Tsumoto K, Uchiyama S, Fukui K (2015) Effects of syringe material and silicone oil lubrication on the stability of pharmaceutical proteins. J Pharm Sci 104(2):527\u2013535","journal-title":"J Pharm Sci"},{"issue":"4","key":"6875_CR18","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1089\/jop.2015.0152","volume":"32","author":"AM Khanani","year":"2016","unstructured":"Khanani AM, Cohen GL, Zawadzki R (2016) A prospective masked clinical assessment of inflammation after intravitreal injection of ranibizumab or aflibercept. J Ocul Pharmacol Ther 32(4):216\u2013218","journal-title":"J Ocul Pharmacol Ther"},{"issue":"9","key":"6875_CR19","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.oret.2019.04.006","volume":"3","author":"JP Greenberg","year":"2019","unstructured":"Greenberg JP, Belin P, Butler J, Feiler D, Mueller C, Tye A et al (2019) Aflibercept-Related sterile intraocular inflammation outcomes. Ophthalmol Retina 3(9):753\u2013759","journal-title":"Ophthalmol Retina"},{"issue":"1","key":"6875_CR20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12348-015-0069-5","volume":"6","author":"MM Sachdeva","year":"2016","unstructured":"Sachdeva MM, Moshiri A, Leder HA, Scott AW (2016) Endophthalmitis following intravitreal injection of anti-VEGF agents: long-term outcomes and the identification of unusual micro-organisms. J Ophthalmic Inflamm Infect 6(1):2","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"1","key":"6875_CR21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4274\/tjo.galenos.2020.84042","volume":"51","author":"M Kaya","year":"2021","unstructured":"Kaya M, \u00d6ner FH, Akbulut Ya\u011fc\u0131 B, Ata\u015f F, \u00d6zt\u00fcrk T (2021) Non-infectious intraocular inflammation following intravitreal anti-vascular endothelial growth factor injection. Turk J Ophthalmol 51(1):32\u201337","journal-title":"Turk J Ophthalmol"},{"issue":"10","key":"6875_CR22","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1016\/j.ophtha.2011.02.034","volume":"118","author":"CP Shah","year":"2011","unstructured":"Shah CP, Garg SJ, Vander JF, Brown GC, Kaiser RS, Haller JA (2011) Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. Ophthalmology 118(10):2028\u20132034","journal-title":"Ophthalmology"},{"issue":"5","key":"6875_CR23","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3928\/23258160-20180501-04","volume":"49","author":"NA Yannuzzi","year":"2018","unstructured":"Yannuzzi NA, Gregori NZ, Rosenfeld PJ, Relhan N, Patel NA, Si N et al (2018) Endophthalmitis associated with intravitreal injections of anti-VEGF agents at a tertiary referral center: in-house and referred cases. Ophthalmic Surg Lasers Imaging Retina 49(5):313\u2013319","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"6875_CR24","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ajo.2016.02.028","volume":"165","author":"N Rayess","year":"2016","unstructured":"Rayess N, Rahimy E, Storey P, Shah CP, Wolfe JD, Chen E et al (2016) Postinjection endophthalmitis rates and characteristics following intravitreal bevacizumab, ranibizumab, and aflibercept. Am J Ophthalmol 165:88\u201393","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"6875_CR25","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.ophtha.2018.01.022","volume":"125","author":"K Xu","year":"2018","unstructured":"Xu K, Chin EK, Bennett SR, Williams DF, Ryan EH, Dev S et al (2018) Endophthalmitis after intravitreal injection of vascular endothelial growth factor inhibitors: management and visual outcomes. Ophthalmology 125(8):1279\u20131286","journal-title":"Ophthalmology"},{"issue":"4","key":"6875_CR26","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1177\/2474126420930863","volume":"4","author":"AJ Witkin","year":"2020","unstructured":"Witkin AJ, Hahn P, Murray TG, Arevalo JF, Blinder KJ, Choudhry N et al (2020) Occlusive retinal vasculitis following intravitreal brolucizumab. J Vitreoretin Dis 4(4):269\u2013279","journal-title":"J Vitreoretin Dis"},{"key":"6875_CR27","doi-asserted-by":"publisher","first-page":"100680","DOI":"10.1016\/j.ajoc.2020.100680","volume":"18","author":"SJ Haug","year":"2020","unstructured":"Haug SJ, Hien DL, Uludag G, Ngoc TTT, Lajevardi S, Halim MS et al (2020) Retinal arterial occlusive vasculitis following intravitreal brolucizumab administration. Am J Ophthalmol Case Rep 18:100680","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"2","key":"6875_CR28","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3109\/09286586.2015.1122067","volume":"23","author":"JE Knickelbein","year":"2016","unstructured":"Knickelbein JE, Chew EY, Sen HN (2016) Intraocular inflammation following intravitreal injection of anti-VEGF medications for neovascular age-related macular degeneration. Ophthalmic Epidemiol 23(2):69\u201370","journal-title":"Ophthalmic Epidemiol"},{"issue":"6","key":"6875_CR29","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1177\/24741264221116487","volume":"6","author":"R Merani","year":"2022","unstructured":"Merani R, Johnson MW, McCannel CA, Flynn HW Jr., Scott IU, Hunyor AP (2022) Clinical practice update: management of infectious endophthalmitis after intravitreal anti-VEGF injection. J Vitreoretin Dis 6(6):443\u2013451","journal-title":"J Vitreoretin Dis"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-06875-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-025-06875-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-06875-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:01:22Z","timestamp":1762160482000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-025-06875-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["6875"],"URL":"https:\/\/doi.org\/10.1007\/s00417-025-06875-w","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"type":"print","value":"0721-832X"},{"type":"electronic","value":"1435-702X"}],"subject":[],"published":{"date-parts":[[2025,6,16]]},"assertion":[{"value":"17 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Ethics Review Board of Local Health Unit of S\u00e3o Jo\u00e3o, Porto, Portugal. The protocol conformed with the canons of the Declaration of Helsinki for research involving human participants, as well as the European Union\u2019s General Data Protection Regulation. Informed consent was waived in view of the prospective nature of the study. This article was redacted according to the recommendations of The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}